Codexis, Inc. (CDXS)

CIK 0001200375 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
— Q2-2026 8-K (2026-07-23)
Latest Q1-2026 8-K (2026-05-07) · 99.1
Latest FY-2025 8-K (2026-03-11) · 99.1
Q3-2025 8-K (2025-11-06) · 99.1
Q2-2025 8-K (2025-08-13) · 99.1
Q1-2025 8-K (2025-05-14) · 99.1
FY-2024 8-K (2025-02-27) · 99.1
Q3-2024 8-K (2024-10-31) · 99.1
Q2-2024 8-K (2024-08-08) · 99.1
Q1-2024 8-K (2024-05-02) · 99.1
FY-2023 8-K (2024-02-28)  |  8-K (2024-01-09)
Q3-2023 8-K (2023-11-02) · 99.1
Q2-2023 8-K (2023-08-03) · 99.1  |  8-K (2023-07-20) · 99.1

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Cover Page
Audit Information
—
Statements
Consolidated Balance Sheets
Consolidated Balance Sheets (P)
Consolidated Statements of Operations
Consolidated Statements of Comprehensive Loss
Consolidated Statements of Operations (P)
Consolidated Statements of Stockholders' Equity
Consolidated Statements of Cash Flows
Consolidated Statements of Stockholders' Equity (P)
Consolidated Statements of Cash Flows (P)
Notes
401(k) Plan
—
Allowance For Credit Losses
Assets Held For Sale
—
Balance Sheet Details
Basis of Presentation and Summary of Significant Accounting Policies
Capital Stock
Collaborative Arrangements
—
Commitments and Contingencies
Cybersecurity Risk Management and Strategy Disclosure
—
Debt
Description of Business
Fair Value Measurements
Income Taxes
—
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Investments In Non-marketable Securities
Net Loss Per Share
Pay Vs Performance Disclosure
Related Party Transactions
Restructuring Charges
Revenue Recognition
Segment, Geographical and Other Revenue Information
Stock-based Compensation
Subsequent Events